Filter
5988
Filtered Results: 5988
Text search:
Centers
for
Disease
Control
and
Prevention
,
World
Health
Organization
WHO
Featured
Recommendations
630
New Publications
1612
Language
Document type
No document type
3283
Studies & Reports
979
Guidelines
852
Manuals
316
Strategic & Response Plan
262
Fact sheets
123
Training Material
71
Situation Updates
60
Resource Platforms
15
Infographics
10
Brochures
8
Online Courses
5
Dashboards/Maps
2
App
2
Countries / Regions
India
272
Global
257
Kenya
175
Sierra Leone
162
Liberia
152
Ethiopia
135
Nigeria
131
Western and Central Europe
126
Uganda
112
Africa
105
Latin America and the Carribbean
96
South Africa
96
Nepal
91
Zambia
84
Malawi
83
Tanzania
82
Rwanda
81
Bangladesh
69
Ukraine
64
Ghana
62
Philippines
60
Syria
59
Congo, Democratic Republic of
59
Myanmar / Burma
59
Guinea
53
Namibia
53
Eastern Europe
52
Mozambique
50
West and Central Africa
48
Russia
48
Middle East and North Africa
46
Zimbabwe
43
South–East Asia Region
43
South Sudan
42
East and Southern Africa
39
Senegal
38
Cambodia
37
Asia
37
Lesotho
34
Haiti
31
Germany
29
Brazil
29
Yemen
28
Burkina Faso
27
Indonesia
27
Eastern Europe and Central Asia
25
Botswana
23
Madagascar
20
Eswatini/ Swaziland
17
Colombia
16
Venezuela
16
Pakistan
16
Cameroon
15
Afghanistan
15
Mali
15
Thailand
14
Somalia
14
USA
13
Western Pacific Region
13
Sudan
13
Côte d’Ivoire / Ivory Coast
12
Central African Republic
12
Tajikistan
11
Albania
11
Moldova
11
Angola
11
Vietnam
10
China
9
Laos
9
North America
9
Benin
8
Guinea-Bissau
8
Jordan
8
Argentina
8
Lebanon
8
Georgia
8
North Macedonia
7
Togo
7
Niger
7
Burundi
7
Iraq
7
Chile
6
Peru
6
Armenia
6
Saudi Arabia
6
Paraguay
6
Timor Leste/ East Timor
5
Gambia
5
Papua New Guinea
5
Sri Lanka
5
Romania
5
Palestine
5
Poland
5
Chad
5
Turkey
4
Kazakhstan
4
Hungary
4
Japan
4
Spain
4
Egypt
4
Libya
4
Ecuador
4
Mexico
3
El Salvador
3
Iran
3
Canada
3
Turkmenistan
3
Tunisia
3
Belarus
3
Southern Africa
3
Honduras
3
Bhutan
3
Estonia
2
Kyrgyzstan
2
Congo-Brazzaville
2
Uzbekistan
2
Malaysia
2
Morocco
2
Qatar
2
Bulgaria
2
Mauritania
2
Gabon
2
Jamaica
2
France
2
Mauritius
2
Bolivia
2
Slovakia
2
Greece
2
North Korea
1
Serbia
1
Singapore
1
Italy
1
Dominican Republic
1
Cape Verde
1
Lithuania
1
Ireland
1
Uruguay
1
Belgium
1
Maldives
1
United Kingdom
1
Morocco
1
Israel
1
Djibouti
1
Authors & Publishers
Publication Years
Category
Countries
2229
Clinical Guidelines
513
Public Health
388
Key Resources
322
Women & Child Health
237
Capacity Building
84
Pharmacy & Technologies
69
Annual Report MEDBOX
2
Toolboxes
COVID-19
665
HIV
493
TB
410
Mental Health
347
Ebola & Marburg
272
Rapid Response
251
AMR
213
NTDs
201
Planetary Health
162
NCDs
141
Caregiver
134
Conflict
122
Refugee
101
Disability
92
Global Health Education
84
Pharmacy
83
Zika
71
Health Financing Toolbox
62
Natural Hazards
55
Cholera
54
Polio
39
Specific Hazards
31
Malaria
12
Social Ethics
7
South Sudan
2
Typhoon
2
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
a window of particular vulnerability, where enviro...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role in preventing and controlling epidemics and they are best able to take a...
The South African WHO Country Cooperation Strategy (CCS) 2023–2027 focuses on four key strategic priorities based on the country’s health needs and disease epidemiology, while also considering the need for building resilient health systems for UHC and health security in the post pandemic period....
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendations on antenatal care for a positive pregnancy experience was published in 2016 with the objective of improving the quality of routine health care that all women and adolescent girls receive during pregnan...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care manag...
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
